Other endocrine and/or neuroendocrine sources are likely to contribute plasma VGF peptides, including at least adrenal gland [25], pituitary [26] and ovary [33], though possible changes in VGF peptide profiles upon obesity and/or diabetes in such locations are as yet undetermined. This evidence concerns the gene VGF and obesity disorder.